118 related articles for article (PubMed ID: 15460851)
1. Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge.
Pezzilli R; Ceciliato R; Corinaldesi R; Barakat B
Dig Liver Dis; 2004 Sep; 36(9):639-40. PubMed ID: 15460851
[No Abstract] [Full Text] [Related]
2. Report of simultaneous acute pancreatitis and acute hepatitis in a patient taking ezetimibe/simvastatin.
Van Woerkom RC; Adler DG
J Clin Lipidol; 2010; 4(4):314-5. PubMed ID: 21122666
[No Abstract] [Full Text] [Related]
3. A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment.
Antonopoulos S; Mikros S; Kokkoris S; Protopsaltis J; Filioti K; Karamanolis D; Giannoulis G
JOP; 2005 May; 6(3):264-8. PubMed ID: 15883478
[TBL] [Abstract][Full Text] [Related]
4. [A new case of simvastatin-induced acute pancreatitis].
Couderc M; Blanc P; Rouillon JM; Bauret P; Larrey D; Michel H
Gastroenterol Clin Biol; 1991; 15(12):986-7. PubMed ID: 1783261
[No Abstract] [Full Text] [Related]
5. [Simvastatin-induced acute pancreatitis: two cases].
Ramdani M; Schmitt AM; Liautard J; Duhamel O; Legroux P; Gislon J; Pariente EA; Agay D; Faure D
Gastroenterol Clin Biol; 1991; 15(12):986. PubMed ID: 1783260
[No Abstract] [Full Text] [Related]
6. [Simvastatin: a new drug responsible for acute pancreatitis?].
Lons T; Chousterman M
Gastroenterol Clin Biol; 1991; 15(1):93-4. PubMed ID: 2010079
[No Abstract] [Full Text] [Related]
7. Acute pancreatitis due to pravastatin therapy.
Anagnostopoulos GK; Tsiakos S; Margantinis G; Kostopoulos P; Arvanitidis D
JOP; 2003 May; 4(3):129-32. PubMed ID: 12743419
[TBL] [Abstract][Full Text] [Related]
8. Long-term statin therapy appears safe.
Harv Heart Lett; 1999 Aug; 9(12):6-7. PubMed ID: 10402353
[No Abstract] [Full Text] [Related]
9. The efficacy of simvastatin is not influenced by CYP2D6 polymorphism.
Geisel J; Kivistö KT; Griese EU; Eichelbaum M
Clin Pharmacol Ther; 2002 Nov; 72(5):595-6. PubMed ID: 12426523
[No Abstract] [Full Text] [Related]
10. Ezetimibe + simvastatin (Merck/Schering-Plough).
Flores NA
Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
[TBL] [Abstract][Full Text] [Related]
11. Safe use of ezetimibe plus simvastatin in high-risk vascular patients (with chronic kidney disease and PAD).
Aalbers J
Cardiovasc J Afr; 2011; 22(4):227-8. PubMed ID: 21881698
[No Abstract] [Full Text] [Related]
12. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
Lasocki A; Vote B; Fassett R; Zamir E
Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin + ezetimibe: a combination with no proven advantages.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
[No Abstract] [Full Text] [Related]
14. [On the current debate on lowering LDL cholesterol with ezetimibe].
Breuer HW
Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
[No Abstract] [Full Text] [Related]
15. Rhabdomyolysis in prostate cancer--caution in prescribing cyproterone acetate with statins.
Ahamed E; Bissett D
Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):528-9. PubMed ID: 15630845
[No Abstract] [Full Text] [Related]
16. Acute generalized exanthematous pustulosis induced by simvastatin.
Oskay T; Kutluay L
Clin Exp Dermatol; 2003 Sep; 28(5):558-9. PubMed ID: 12950356
[No Abstract] [Full Text] [Related]
17. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
Krysiak R; Zmuda W; Okopien B
Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
[TBL] [Abstract][Full Text] [Related]
18. Sporadic rippling muscle disease unmasked by simvastatin.
Baker SK; Tarnopolsky MA
Muscle Nerve; 2006 Oct; 34(4):478-81. PubMed ID: 16688722
[TBL] [Abstract][Full Text] [Related]
19. Relapsing acute pancreatitis induced by re-exposure to the cholesterol lowering agent bezafibrate.
Gang N; Langevitz P; Livneh A
Am J Gastroenterol; 1999 Dec; 94(12):3626-8. PubMed ID: 10606331
[TBL] [Abstract][Full Text] [Related]
20. A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease.
Rosen JB; Jimenez JG; Pirags V; Vides H; Hanson ME; Massaad R; McPeters G; Brudi P; Triscari J
Diab Vasc Dis Res; 2013 May; 10(3):277-86. PubMed ID: 23288881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
